TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

PHARMEDIUM

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: WordOffice: US

Quick snapshot

PHARMEDIUM

ST13

US500000076585525

Class

5

Filing

76585525

Registration

3445636

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

Attention: there is active risk

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

69

Latest update

06/12/2018

Classification

Registered

Trademark type

Word

Nice classes

5

Filing date

04/07/2004

Registration date

06/10/2008

Expiration date

-

Recommended action

Perform a full collision analysis and validate classes before any filing or trademark investment.

Next step

These are the details of the registration process. Even so, constant monitoring is what ensures peace of mind that your main asset remains protected.

Complete case details

Structured fields from the responsible authority and the official record.

Status date

06/12/2018

Last transaction

06/12/2018

Responsible office

United States Patent and Trademark Office

Status code

800

Official register

Principal Register

Filing basis

Intent to use

First use anywhere

2007-11-00

First use in commerce

2007-11-00

Drawing code

4

Owner type

16

Owner location

LAKE FOREST, IL

Examiner

PHAM,LANA H

Law office

M60

Current location

GENERIC WEB UPDATE

Holders and representatives

Holders

PHARMEDIUM SERVICES, LLC
P. C. (pessoa física)
P. C. (pessoa física)

Representatives

Barry W. Sufrin Michael Best & Friedrich LLP

Technical classification

Nice Classes

Class 5

Vienna Codes

No Vienna codes available.

Goods and services

Class 5

Anesthetic for surgical purposes; Anesthetics for non-surgical use; Anesthetics for surgical use; Anti-infectives; Antibacterial pharmaceuticals; Antibiotics; Antihypertensives; Cardiovascular pharmaceuticals; Cardiovascular treatment preparations; Electrolytes [ ; Nutritional supplements ]

Publications

History of USPTO decisions and trademark events.

69 publications found

NA89

NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED

06/12/2018

RNL1

REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)

06/12/2018

89AG

REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED

06/12/2018

APRE

CASE ASSIGNED TO POST REGISTRATION PARALEGAL

06/12/2018

E89R

TEAS SECTION 8 & 9 RECEIVED

06/01/2018

REM2

COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED

06/10/2017

TCCA

TEAS CHANGE OF CORRESPONDENCE RECEIVED

04/03/2017

ARAA

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

03/01/2016

REAP

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

03/01/2016

ASCK

ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY

09/02/2015

NA85

NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED

01/11/2014

C15A

REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.

01/11/2014

APRE

CASE ASSIGNED TO POST REGISTRATION PARALEGAL

01/11/2014

815F

REGISTERED - SEC. 8 (6-YR) & SEC. 15 FILED

01/07/2014

E815

TEAS SECTION 8 & 15 RECEIVED

01/07/2014

ASCK

ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY

01/01/2014

ARAA

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

04/12/2013

REAP

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

04/12/2013

ARAA

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

11/10/2011

REAP

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

11/10/2011

R.PR

REGISTERED-PRINCIPAL REGISTER

06/10/2008

REGV

LAW OFFICE REGISTRATION REVIEW COMPLETED

05/03/2008

CNPR

ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED

05/02/2008

ACEC

AMENDMENT FROM APPLICANT ENTERED

03/28/2008

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

03/28/2008

CHAN

APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED

03/28/2008

ALIE

ASSIGNED TO LIE

03/28/2008

MAIL

PAPER RECEIVED

03/20/2008

ARAA

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

02/25/2008

REAP

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

02/25/2008

GNRN

NOTIFICATION OF NON-FINAL ACTION E-MAILED

01/14/2008

GNRT

NON-FINAL ACTION E-MAILED

01/14/2008

CNRT

SU - NON-FINAL ACTION - WRITTEN

01/14/2008

SUPC

STATEMENT OF USE PROCESSING COMPLETE

01/07/2008

IUAF

USE AMENDMENT FILED

12/10/2007

EISU

TEAS STATEMENT OF USE RECEIVED

12/10/2007

ASGN

AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP

10/31/2007

ASCK

ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY

10/24/2007

EX5G

SOU EXTENSION 5 GRANTED

06/08/2007

EXT5

SOU EXTENSION 5 FILED

06/08/2007

EEXT

SOU TEAS EXTENSION RECEIVED

06/08/2007

EX4G

SOU EXTENSION 4 GRANTED

12/12/2006

EXT4

SOU EXTENSION 4 FILED

12/12/2006

EEXT

SOU TEAS EXTENSION RECEIVED

12/12/2006

EX3G

SOU EXTENSION 3 GRANTED

06/12/2006

EXT3

SOU EXTENSION 3 FILED

06/12/2006

EEXT

SOU TEAS EXTENSION RECEIVED

06/12/2006

ARAA

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

06/06/2006

REAP

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

06/06/2006

COAR

TEAS CHANGE OF OWNER ADDRESS RECEIVED

01/04/2006

EX2G

SOU EXTENSION 2 GRANTED

12/12/2005

EXT2

SOU EXTENSION 2 FILED

12/12/2005

EEXT

SOU TEAS EXTENSION RECEIVED

12/12/2005

EX1G

SOU EXTENSION 1 GRANTED

06/14/2005

EXT1

SOU EXTENSION 1 FILED

06/14/2005

EEXT

SOU TEAS EXTENSION RECEIVED

06/14/2005

NOAM

NOA MAILED - SOU REQUIRED FROM APPLICANT

12/14/2004

PUBO

PUBLISHED FOR OPPOSITION

09/21/2004

NPUB

NOTICE OF PUBLICATION

09/01/2004

PREV

LAW OFFICE PUBLICATION REVIEW COMPLETED

08/06/2004

ALIE

ASSIGNED TO LIE

08/06/2004

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

07/09/2004

ZZZX

PREVIOUS ALLOWANCE COUNT WITHDRAWN

07/09/2004

CNEA

EXAMINERS AMENDMENT MAILED

07/08/2004

ZZZX

PREVIOUS ALLOWANCE COUNT WITHDRAWN

07/07/2004

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

05/13/2004

CNEA

EXAMINER'S AMENDMENT MAILED

05/11/2004

DOCK

ASSIGNED TO EXAMINER

05/06/2004

NWAP

NEW APPLICATION ENTERED

04/26/2004

Continuous trademark protection

Get notified about every new filing that threatens PHARMEDIUM or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.